A tipster inside the pharmaceutical company that produces the monoclonal antibodies proven to be effective in treating individuals with Covid-19 tells Americans for Limited Government that there is “no supply shortage of the monoclonal antibodies at this time.” This is in direct contrast with the narrative the Biden White House is pushing as the reason for rationing the treatment in Red states such as Florida where the federal government has reduced shipments of the treatment by half in recent days.